Pathology of Demyelinating Disease
-
Upload
ml-cohen -
Category
Health & Medicine
-
view
26 -
download
3
description
Transcript of Pathology of Demyelinating Disease
![Page 1: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/1.jpg)
“Demyelinating” diseases
Mark L Cohen, M.D.Department of Pathology
University Hospitals Case Medical CenterJanuary 6th, 2009
![Page 2: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/2.jpg)
Learning Objectives
• Describe an algorithmic approach to the differential diagnosis of a patient with white matter disease.
• Provide examples of diseases representing the three major categories of leukoencephalopathies (genetic, acquired non-inflammatory & inflammatory) and discuss diagnostic features of each.
• Discuss the pathophysiology of Charcot’s triad, Uhthoff’s phenomenon, and L’hermitte’s symptom.
![Page 3: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/3.jpg)
Normal myelinated axon
• Lipid-rich myelin sheath produced by oligodendrocytes• Axon insulation• Sodium channels clustered at nodes of Ranvier• Increased conduction speed and metabolic efficiency
![Page 4: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/4.jpg)
Demyelination
• Decreased conduction velocity or block• Destablization of axonal cytoskeleton• Remodelling of internodal membrane• Progressive axonal loss
![Page 5: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/5.jpg)
Oligodendroglial pathology
• Inborn errors– Leukodystrophies
• Acute injury– Inflammatory (multiple sclerosis and related
disorders)– Toxic and metabolic disturbances
• Chronic injury– Multiple system atrophy, progressive supranuclear
palsy
• Viral infection– Progressive multifocal leukoencephalopathy
• Neoplastic transformation– Oligodendrogliomas
![Page 6: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/6.jpg)
Leukoencephalopathies: White matter damage with relative axonal preservation
• Inherited– Lipid, Protein, Mitochondrial,
Vascular• Acquired, non-inflammatory
– Toxic, Metabolic, Vascular, Traumatic
• Acquired, inflammatory– Infectious, Immunologic
![Page 7: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/7.jpg)
MRI in Leukoencephalopathies
• Diffuse (Leukodystrophies)
• Discrete (Multiple sclerosis)
• Diverse (everything else)
![Page 8: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/8.jpg)
Genetic disorders of white matter
• Lipid disorders (e.g. Adrenoleukodystrophy)• Cytoskeletal disorders (e.g. Alexander
disease)• Myelin protein disorders
(e.g Pelizaeus-Merzbacher disease)• Organic acid disorders (e.g Canavan disease)• Disorders of energy metabolism (e.g.
MELAS)
• Other (e.g. CADASIL)
![Page 9: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/9.jpg)
Normal vs. Leukodystrophy (ALD)
![Page 10: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/10.jpg)
Disease Cellular defect
Pathologic features
Metachromatic
Leukodystrophy
Lysosomal Metachromatic sulfatides within
macrophages
Krabbe Disease Lysosomal Globoid (multinucleated)
microglia
Adreno-
leukodystrophy
Peroxisomal Perivascular inflammation
Alexander disease
Cytoskeletal Rosenthal fibers
![Page 11: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/11.jpg)
Subcortical U-fibers
Krabbe Disease Alexander Disease
Now you see ‘em Now you don’t
![Page 12: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/12.jpg)
Globoid cell leukodystrophy (Krabbe)
![Page 13: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/13.jpg)
Adrenoleukodystrophy
Alexander disease
Pelizaeus-Merzbacher Disease
![Page 14: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/14.jpg)
Non-inflammatory Leukoencephalopathies
• Toxic (e.g. antineoplastic agents)• Metabolic (e.g. B12 deficiency)• Vascular (e.g hypertension)• Traumatic (e.g diffuse axonal injury)
![Page 15: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/15.jpg)
Toxic leukoencephalopathies
• Structural alteration of white matter in which myelin suffers most
• Particularly involves tracts devoted to higher cerebral functioning
• Language usually preserved• Focal neurologic signs usually less
prominent than mental status changes
![Page 16: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/16.jpg)
Radiation leukoencephalopathy
• Months to years after therapy (usually doses of 20 Gy or more)
• Vascular damage with hyalinization
• Coagulative necrosis of white matter
![Page 17: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/17.jpg)
Central pontine myelinolysis Marchifava-Bignami disease
![Page 18: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/18.jpg)
Inflammatory Leukoencephalopathies
• Infectious – HIV encephalitis– Progressive multifocal
leukoencephalopathy
• Immunologic – Multiple sclerosis & related disorders
![Page 19: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/19.jpg)
HIV encephalitis
P24 immunostaining
![Page 20: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/20.jpg)
Progressive multifocal leukoencephalopathy
![Page 21: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/21.jpg)
Progressive multifocal leukoencephalopathy
JC virus immunostaining
![Page 22: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/22.jpg)
Carswell, 1838
Babinski, 1885
![Page 23: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/23.jpg)
1868
Nystagmus, intention tremor, scanning speech
Barber Chair phenomenon
Worsening of vision with exercise in optic neuritis
1890 1920
![Page 24: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/24.jpg)
Site Symptoms Signs
Cerebrum Cognitive impairmentAttention deficit, dementia (late)
Optic Nerve Unilateral painful visual loss
Scotoma, afferent pupillary defect
CerebellumTremor
Clumsiness
Intention tremor
Ataxia, dysarthria
Brainstem Diplopia, vertigo, emotional lability
Nystagmus, INO, ophthalmoplegias
Spinal cordSpasms; bowel, bladder, erectile
dysfunctionSpasticity
![Page 25: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/25.jpg)
• Reduced capacitance of thinly or unmyelinated axon segments underlies Uhthoff symptom
• Increased mechanical sensitivity of partially demyelinated axons underlies L’hermitte’s symptom
![Page 26: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/26.jpg)
Clinical DDx of MS
• Systemic diseases with relapsing CNS involvement (vasculitis, collagen vascular disease, B12 deficiency)
• Progressive CNS system degenerations (hereditary ataxias, neuroaxonal dystrophies)
• Focal lesions with relapsing or progressive course (especially CNS tumors)
• Disseminated monophasic disorders (e.g. acute disseminated encephalomyelitis)
• Non-organic symptoms that mimic MS
![Page 27: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/27.jpg)
MS Pathogenesis
•Molecular mimicry causes inappropriate migration of autoreactive myelin T cells across the blood-brain barrier, initiating an inflammatory reaction against proteins of the oligodendrocyte-myelin unit•T cells activated by IL-23 secrete IL-17, disrupting the blood-brain barrier•Th17 cells and activated microglia damage glia, axons, and neurons
![Page 28: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/28.jpg)
Glia limitans perivascularis
![Page 29: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/29.jpg)
2 steps to neuroinflammation
1 2
Glia limitans perivascularis
Post-capillary venule
![Page 30: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/30.jpg)
![Page 31: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/31.jpg)
Active demyelinating plaque
CD68 IHC
![Page 32: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/32.jpg)
Gross pathology
![Page 33: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/33.jpg)
Gross pathology
![Page 34: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/34.jpg)
Inactive plaque
![Page 35: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/35.jpg)
MS: Active & inactive plaques
![Page 36: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/36.jpg)
Evolution of an MS plaque
![Page 37: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/37.jpg)
Axonal pathology in MS
• Plaque associated axonal swellings (Charcot, 1880)
• More axons lost than generally believed (Marburg, 1906)
• Axonal sprouts arising from terminal spheroids (Jakob, 1915)
• Axonal transections in MS (Trapp et.al., NEJM, 1998)
• Nitric oxide donors produce reversible conduction block
• Prolonged NO causes NMDA receptor mediated toxicity
• Loss of oligodendroglial IGF1 support contributes to neuronal & axonal loss
![Page 38: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/38.jpg)
Primary demyelination vs. primary neuroaxonal degeneration
Primary demyelination demonstrates:
• Lack of anatomic restriction
• Extension to pial surface
• Complete absence of myelin (occasionally with partial loss at interface secondary to remyelination)
![Page 39: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/39.jpg)
MS: Recent advances
• Remyelination occurs in ~20% of people with MS, and is probably an important factor in re-establishing conduction
• Premyelinating oligodendrocytes are present in MS plaques
• In chronic MS plaques, persisting axons appear unreceptive to remyelination
![Page 40: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/40.jpg)
Learning Objectives
• Describe an algorithmic approach to the differential diagnosis of a patient with white matter disease.
• Provide examples of diseases representing the three major categories of leukoencephalopathies (genetic, acquired non-inflammatory & inflammatory) and discuss diagnostic features of each.
• Discuss the pathophysiology of Charcot’s triad, Uhthoff’s phenomenon, and L’hermitte’s symptom.
![Page 41: Pathology of Demyelinating Disease](https://reader033.fdocuments.us/reader033/viewer/2022061111/545599deaf7959b53e8b5a54/html5/thumbnails/41.jpg)
References
• Compston A, Coles A. Multiple sclerosis. Lancet. 2008 Oct 25;372(9648):1502-17.
• Owens T, Bechmann I, Engelhardt B. Perivascular spaces and the two steps to neuroinflammation. J Neuropathol Exp Neurol. 2008 Dec;67(12):1113-21.